Audited Supplier
In This Store
Shaanxi Meihe Biochemics Co.,Ltd is a professional developer, Researcher, Manufacturer, Supplier and Exporter specialized in Botanical Extract, API, Natural Healthcare Food Additives, Cosmetic Raw Material and Chemical Intermediates to the Pharmaceutical, Food, Nutritional, Cosmetic industries.
Since it was founded in 2008, Shaanxi Meihe Biochemics Co., Ltd. specializes in various Plant Extracts and Pharmaceutial Intermediates, such as Ginkgo Biloba Extract, Soybean Extract, Rutin, Grape Seed Extract, Polygonum Cuspidatum Extract, Marigold Extract, Ginger Extract, Garlic Extract, Epimedium Extract, Berberine HCL, Rotundine, L-(+)-Ergothioneine, L-glutathione, (S)-Pro-xylane, Ectoin, etc., which are widely used in food, cosmetics, nutritional, pharmaceutical and feed industry.
MeiheBio has passed ISO 9001 & ISO 22000 certification and the third-party audit by German QUALIFYZE. Due to the excellent quality, reasonable prices and good after-sales service, MeiheBio has earned a long-lasting good reputation in the domestic and international market. Products have been exported to Europe, the United States, Brazil, Australia and Southeast Asian countries. Many foreign customers have built a more than 10 years stable partnership with MeiheBio. We will continuously provide good competitive products and serve for customers at home and abroad, new and old.
Year of Establishment: 2008
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: Excellent Quality Reasonable Prices Good After-sale Service Many stable customers(most of them have been cooperating with Meihe Biochemics for more that 10 years)
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
